期刊文献+

氮氧化钛涂层支架在冠状动脉血运重建中的初步应用 被引量:4

Initial use of trans-ulner or trans-radial approach to coronary revascularization with titanium-nitride-oxidecoated stent
原文传递
导出
摘要 目的探讨氮氧化钛涂层(TITAN2)支架在经彬尺动脉途径行冠状动脉血运重建的临床效果。方法入选31例冠心病患者,均采用经桡动脉或尺动脉途径行冠状动脉血运重建。计算TITAN2支架病变的通过率、早期支架内血栓发生率及随访MACE发生率。结果31例冠状动脉造影发现46处〉75%狭窄病变,植入支架45枚,1枚支架未能通过病变,通过率97.8%。植入支架后无残余狭窄、支架脱载、内膜撕裂、支架内早期血栓形成及冠状动脉破裂。随访1~5个月,无MACE发生。结论TITAN2支架在冠状动脉血运重建方面临床应用效果良好。 Objective To evaluate the efficacy of trans-ulner or trans-radial approach to coronary revascularization with titanium-nitride-oxide-coated stent ( TITAN2 ). Methods 31 patients, who were planed to receive coronary revascularization,were selected into this study. All patients with coronary revascularization were either by trans-ulner or by trans-radial approach. The pass-through rate of stent, early thrombosis in stent and MACE at followup were recorded for TITAN2. Results 46 lesions with stenosis 〉 75% with coronary angiography in 31 patients successfully underwent coronary revascularization with TITAN2. One stent didn't go through the lesion in RCA. The pass-through rate of stent was 97.8%. Remaining stenosis, stent unglues, endarterium laceration, early thrombosis in stent and coronary rupture were not discovered after stent deployment. MACE was 0 at 1-5 month follow-up. Conclusion Confirmed good efficacy in coronary revascularization with TITAN2 is observed.
出处 《中国综合临床》 北大核心 2008年第8期804-805,共2页 Clinical Medicine of China
关键词 冠状动脉血运重建 氮氧化钛涂层支架 Coronary revascularization Titanium-nitride-oxide-coated stent
  • 相关文献

参考文献7

  • 1Windecker S, Simon R, Lins M, et al. Randomized comparison of a titanium-nitride-oxide-coated stent with a stainless steel stent for coronary revascularization the TiNOX trial [ J ]. Circulation, 2005, 111(1):1-6.
  • 2Windecker S, Isabella M, Pasquale GD, et al. Stent coating with titanium-nitride-oxide for reduction of neointimal hyperplasia [ J ]. Circulation,2001,104 (5) :928-933.
  • 3Zhang F, Zheng ZH, Chen Y, et al. In vivo investigation of blood compatibility of titanium oxide films [ J ]. J Biomed Mater Res, 1998,42(3) :128-133.
  • 4吴震平,郭东,何志华,王雪樵.药物涂层支架在冠状动脉再狭窄介入治疗中的作用[J].中国医药,2007,2(1):63-64. 被引量:5
  • 5Iakovou I, Schmidt T, Ge L, et al. Incidence and predictors of thrombosis after implantation of drug-eluting stents in unselected patients [J]. ACC March ,2005:1038-1039.
  • 6艾辉,朱小玲,颜红兵,高海,李南,王健,张晓江,李世英.直接经皮冠状动脉介入雷帕霉素药物洗脱支架内血栓形成的临床分析[J].中国医药,2008,3(6):332-334. 被引量:6
  • 7Gotman I. Characteristics of metals used in implants[ J]. Journal of Endourology, 1997,11 (6) :383-389.

共引文献8

同被引文献22

  • 1Windecker S, Simon R, Lins M, et al. Randomized comparison of a titanium-nitride-oxide-coated stent with a stainless steel stent for coronary revascularization the TiNOX trial[J].Circulation, 2005, 111(20) :2617 -2622.
  • 2Windecker S, Isabella M, Pasquale GD, et al. Stent coating with titanium-nitride-oxide for reduction of neointimal hyperplasia [ J ]. Circulation, 2001, 104 (8) :928 - 933.
  • 3Zhang F, Zheng ZH, Chen Y, et al. In vivo investigation of blood compatibility of titanium oxide films [J]. J Biomed Mater Res, 1998, 42(2) :128 -133.
  • 4Bhatt DL, Flather MD, Hacke W, et al. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial [J].J Am Coll Cardiol, 2007, 49 (19): 1982 - 1988.
  • 5Gotman I. Characteristics of metals used in implants [ J]. J Endourol, 1997, 11(6):383-389.
  • 6Windecker S,Simon R,Lins M,et al.Randomized comparison of a titanium-nitride-oxide-coated stent with a stainless steel stent for coronary revascularization the TiNOX trial[J].Circulation,2005,111(20):2617-2622.
  • 7Windecker S,Isabella M,Pasquate GD,et al.Stent coating with titanium-nitride-oxide for reduction of neointimal hyperplasia[J].Circulation,2001,104(8):928-933.
  • 8Zhang F,Zheng ZH,Chen Y,et al.In vivo investigation of blood compatibility of titanium oxide films[J].J Biomed Mater Res,1998,42(1):128-133.
  • 9Bhatt DL,Flather MD,Hacke W,et al.Patients with prior myocardial infarction,stroke,or symptomatic peripheral arterial disease in the CHARISMA trial[J].J Am Goll Cardiol,2007,49(19):1982-1988.
  • 10Gotman I.Characteristics of metals used in implants[J].J Endourol,1997,11(6):383-389.

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部